- Home
- PAX vs RLAY Comparison
PAX vs RLAY Comparison
Compare PAX & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PAX | RLAY |
|---|---|---|
| Founded | 1988 | 2015 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.5B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PAX | RLAY |
|---|---|---|
| Price | $12.98 | $12.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $18.00 | ★ $19.50 |
| AVG Volume (30 Days) | 658.7K | ★ 3.1M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.81% | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,355,000.00 |
| Revenue This Year | $12.99 | N/A |
| Revenue Next Year | $16.52 | $324.03 |
| P/E Ratio | $25.65 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $11.05 | $2.71 |
| 52 Week High | $17.80 | $17.32 |
Technical Indicators
Market Signals| Indicator | PAX | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 55.03 | 45.12 |
| Support Level | $12.81 | $6.67 |
| Resistance Level | $13.07 | $17.32 |
| Average True Range (ATR) | 0.35 | 1.02 |
| MACD | -0.01 | -0.47 |
| Stochastic Oscillator | 52.05 | 19.21 |
Price Performance
Historical ComparisonAbout PAX Patria Investments Limited
Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.